32 results
8-K
EX-99.1
BEAM
Beam Therapeutics Inc
14 Dec 23
Beam Therapeutics Appoints Biotech Executive Christi Shaw to its Board of Directors
4:05pm
several leadership positions at Johnson & Johnson. She serves as a member of the board of directors of Avantor and is the co-founder of the More Moments
8-K
EX-99.1
BEAM
Beam Therapeutics Inc
19 Oct 23
Cost Associated with Exit or Disposal Activities
8:50am
option at end of P1/2 for 35% WW cost/net profit split on one program Next-gen RNA and delivery; Beam provides interim leadership and RNA/LNP
8-K
EX-99.1
585h1huowsnmt40
10 May 23
Beam Therapeutics Reports Pipeline Updates and First Quarter 2023 Financial Results
7:00am
8-K
wd8nh9uew70yjz
7 Sep 22
Other Events
6:47am
8-K
EX-99.1
0yd6t1 exfxvcyghl820
9 May 22
Beam Therapeutics Announces Pipeline and Business Highlights and Reports First Quarter 2022 Financial Results
7:01am
8-K
EX-99.1
7s7pyg 0rswpsjg
10 Jan 22
Results of Operations and Financial Condition
6:45am
8-K
EX-99.1
qogdhyo1 thao
8 Nov 21
Beam Therapeutics Provides Business and Pipeline Updates and Reports Third Quarter 2021 Financial Results
6:19am
8-K
EX-99.1
qst202 8hu4
11 May 21
Beam Therapeutics Presents LNP Formulation Data at ASGCT and Reports First Quarter 2021 Financial Results
7:48am
DEF 14A
iethizsj
23 Apr 21
Definitive proxy
4:05pm
8-K
EX-99.1
ivk4g 0y3cqk8
15 Mar 21
Beam Therapeutics Announces Business and Pipeline Progress and Reports Fourth Quarter and Full Year 2020 Financial Results
6:45am
8-K
EX-99.1
vtd44hofo1ngu2
10 Nov 20
Beam Therapeutics Announces Business and Pipeline Progress and Reports Third Quarter 2020 Financial Results
6:41am
424B4
qm7baeg
1 Oct 20
Prospectus supplement with pricing info
4:21pm